UTILIZING TARGETED IMMUNOTHERAPY TO REDUCE ONCOLOGIC CHEMORADIOTHERAPY IN CAYA WITH ADVANCED MB-NHL

IF 2.2 4区医学 Q3 HEMATOLOGY

Leukemia research Pub Date : 2025-09-01 DOI:10.1016/j.leukres.2025.107956

Anthony Audino, Kayleigh Clark, Aliza Gardenswartz, Jessica Hochberg, Jaclyn Basso, Ana C. Xavier, Rodney R. Miles, Stephan D. Voss, Samir Kahwash, Suzanne Braniecki, Megan Lim, Lauren Harrison, Stanton Goldman, Mitchell S. Cairo

引用次数: 0

查看原文本刊更多论文

利用靶向免疫治疗减少晚期mb-nhl患者的肿瘤放化疗

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia research 医学-血液学

CiteScore

4.00

自引率

3.70%

发文量

259

审稿时长

1 months

期刊介绍： Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.